PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.
Clinical trial NCT05530200 · UNKNOWN
Trial details
- NCT number
- NCT05530200
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.